To target PDAC, allogeneic tumor cells virally transduced with GM-CSF (GVAX) were combined with (A) chemotherapy, (B) chemotherapy plus nivolumab (αPD-1), or (C) all of the previous plus urelumab (CD137 agonist).86 Here, CSF2 is linked to neoplasm.